Moving at the Speed of Science

Our Science
NoShortcutsStill_790X500.jpg
NoShortcutsStill_1000X450.jpg

Moving at the Speed of Science

An open letter from our Chairman and CEO on working together to build trust in science.

COVID-19 INFORMATION AND RESOURCES

Your Health
man_lab_dark_380x500.png
man_lab_dark_1000x450_0.jpg

COVID-19 INFORMATION AND RESOURCES

Current information on our scientific progress to bring forward a safe and effective vaccine to help protect against the novel coronavirus.

COVID-19 Vaccine Development

Our Science
woman_holding_vial_380X500.jpg
woman_holding_vial_1000X450.jpg

COVID-19 Vaccine Development

Rapid progress on the path to develop, test and manufacture a vaccine.

STEPS FOR MANAGING FINANCES AND HEALTH INSURANCE AFTER A CANCER DIAGNOSIS

Your Health
Managing_Finances_After_Cancer_Diagnosis_790X500
Managing_Finances_After_Cancer_Diagnosis_1000x450.jpg

STEPS FOR MANAGING FINANCES AND HEALTH INSURANCE AFTER A CANCER DIAGNOSIS

Cost should never be a barrier to receiving cancer treatment, yet there are people who forgo treatment so as not to burden their family with high medical costs.

Find a Trial

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

THE ANTIGEN: #COVID19 PODCAST

Podcasts
the_antigen_image_380x700.png
the_antigen_image_1000x450.jpg

THE ANTIGEN: #COVID19 PODCAST

Season 2 of The Antigen podcast focuses on COVID-19, Pfizer’s response to the crisis and more.

Maintaining Positivity: A Mother and Daughter’s Perspective on Chronic Pain Due to Osteoarthritis

Your Health
Maintaining_Positivity_790x500.png
Maintaining_Positivity_1000x450.jpg

Maintaining Positivity: A Mother and Daughter’s Perspective on Chronic Pain Due to Osteoarthritis

In recognition of Pain Awareness Month, Ann and her daughter Elizabeth (Lizzie) Sullivan sat down with Grace Whiting, President & CEO of the National Alliance for Caregiving, to discuss the impact that chronic pain due to OA can have.

Latest News

Investigational vaccine demonstrated positive safety results and immune responses to 20 S. pneumoniae serotypes in adults and infants Pfizer has submitted to the FDA its biologics license application for adults 18 years of age or older and awaits acceptance for review Pfizer Inc. (NYSE:PFE) today announced the full analysis from one of its Phase 3 studies (NCT03760146), which evaluated the safety and immunogenicity of its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate in adults…